Fierce Pharma6 天
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
Contract Pharma5 天
GSK’s Blujepa Approved by FDA for Treatment of uUTIs
The FDA has approved GSK’s Blujepa for the treatment of female adults and pediatric patients with uncomplicated urinary tract ...
FDA Approves New Oral Antibiotic Blujepa For UTI Treatment In Women And Teens
The FDA has approved Blujepa (gepotidacin), a first-in-class oral antibiotic for uncomplicated urinary tract infections (uUTIs) in women and children aged 12 and older. Clinical trials showed its ...
GSK confirms Blujepa approved by FDA for uUTIs
GSK (GSK) plc announced that the U.S. Food and Drug Administration has approved Blujepa for the treatment of female adults and pediatric ...